Member Info for BOJO2020

Consolidation due IMO.

Too much information to process and not up to speed. What is a good buy in price. Is it a buy? Something tells me 15p sounds right?

Red,

Excellent post but nobody on this thread said he was selling…

Does the the mere mention of Trevors name suggest intrigue and skulduggery?

Mind you, not much else you can do with shares apart from buy, hold and sell em so we are all bound to be right some of the time.

I was really interested in seeing his next move following the placing, as opposed to speculating. Oh well on such things are sentiment built I suppose.

Last post on POLX from me.

Caveat, not comparing eggs with eggs here.

From £1.10p region, FDA failure it dropped to 37p. Already recovered to 64/66p region. That’s a 75% regain from 37…

No matter which way I slice it, this leads to conclude Angle is a firm firm hold until FDA news. If the MM drop this too far it should recover. If it drops a small amount then I miss a top up opportunity but my current holding would be above water.

Of course the likely hood is that approval is imminent.

Sorry to post my strategy in public and I know some find it annoying, but I do view the POLX case and recovery as relevant. I could be wrong so clearly make your own minds up. I have not been doing this long enough to offer advice. Just feeling my way through the dark.

ATB

Trevor,

You are now clear to press the magic buttons and make this baby fly…

On the other hand if you don’t sell the dogs and buy other stocks they turn into dogs. Before you know it the accumulate…

Thinking of renaming my portfolio “Battersea!”

I agree Blahblah,

Comparing Angle and Polx is largely a pointless exercise, however understanding how the MM have chose to deal with the failed FDA application of Polx in terms of SP is worth some note. IMO they applied a too strong a rerate.

Re FDA: the likes of Janet Wood**** and Co, really do strike me as the most fastidious kinds. From what I can tell they have very high standards and gaining their approval whilst not easy would certainly be worth the effort. If anything, Angles previous application and recent communication with FDA should stand us in good stead. I do agree with Chester18 that it will be the technicalities that may well prove pivotal. It may be the things we investors may not perceive that the FDA are most interested in as they foresee consequences we do not and they have experience that we do not. We have to trust Angle. We equally have to trust the FDA. If Parsortix is worthy then we will get approval.

Polx was oversold as they have already gained back 20p so far. Should the same happen here I will buy that dip too.

I honestly can’t see how Parsortix can fail but it depends on the detail of these applications IMO.

FYI

Bought Polx @ 43p. If I could have raised funds hours earlier could have got 37p. As it now sits @ 53 to 54p it is worth considering that the MM got the rerate wrong which created an opportunity…

Just saying if Angle gets the knock back I will pile in hard to mitigate losses. Polx is a clear example of this strategy working. I expect Polx to rest around 60p.

Anyway, bottom line is I am up 25% in 3 days. The 60% drop was overdone.

I am invested in Angle who are currently waiting FDA De Novo approval within weeks. Many similarities between that and Polx. Right now we are where you were last week. A lot to gain however maybe 40 to 60% to lose…

I bought in here @ 43p as it is clearly oversold. Also good to know that if Angle does not get approval, then buying that at the bottom is definitely a good idea. Already up 25% here and I would expect it to level out around 60p pending news.

Learning much about POLX and there is much to like.

Good Luck.

Already 6p…

Well done getting in at those prices. I had restricted funds so bought less @ 5.4p.

Already 6p!

Good Luck all

I also added. One thing i will say for Trev is he leaves obvious signs before blast off

Lololol! Thought he was nearly 30% holder!

Unless he sold some at 7.5p…

Bought them back at 5p…

Hmmm TB alright

Managed to grab a few and will now research deeper.

Lost 60% on FDA refusal. No brainier for me so added that to my list of bio pharmas. Will research heavily now to see if it is a long term hold

The only fact we have re Angle is that yet again the share price is discounted!

Although Nasdaq is just one of the likely ducks that Angle have lined up. They will be knocking these down in a particular order. For now, the Nasdaq duck must wait at the other side of the pond (see what I did there…)

Ian Griffiths and Andrew will have everything lined up so I would not be surprised if it happened fairly shortly. But! It would be happening for all the right reasons I am sure.

If shares are issued in a company and purchased then the company is worth what it sells them for. Why? Because the company has now got an asset (cash). Dependant on what the company used the money for (wages etc would quickly devalue the cash asset) and the company would lose money. Call this cash burn.

If a company were to issue more shares say to go on another market;Nasdaq, then the company would immediately become more valuable except it can’t because it has issued more shares (they balance one another out).

Basically the only way a business can maintain and increase value is by being excellent and adding value by various means over time…

The point of going on Nasdaq would be exposure to US muscle investors. The question right now is would such investors look at any business that is listed on AIM.

Well I would love to have 10x the amount of these shares but for everyone of these shares I buy I spend an equal amount on other biotech pharma. Still learning, still cautious and hope to be rewarded.

Good Luck All